Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
New nomogram better predicts bladder cancer risk
Key clinical point: A new and simple nomogram for predicting the risk of bladder cancer in patients with microscopic hematuria could optimize the diagnostic evaluation process.
Major finding: The area under the curve (AUC) in the training and validation set was 0.79 and 0.74, respectively.
Study details: A retrospective analysis of 4,178 patients with microscopic hematuria.
Disclosures: The study was funded by the National Institutes of Health and the American Association of Medical Colleges. The authors reported having no conflicts of interest.
Citation:
Matulewicz RS et al. Urol Oncol. 2020 Jan 14. doi: 10.1016/j.urolonc.2019.12.010.